Use of metamodels in health economics to bypass complexity and democratize modelling
Talk, ISPOR US 2025, Montréal, Quebec, Canada
This study outlines the potential usage of neural-network-based metamodels within health economics.
Conferences, talks and presentations
The prevalence of multi-comorbid patients in the US: highlighting the need for multi-indication value assessments
Poster, ISPOR US 2025, Montréal, Quebec, Canada
This study estimates the population-level prevalence of seven interrelated diseases within the US, describes the substantial overlap between these diseases, and quantifies the prevalence of multi-comorbid patients.
Targeted Interventions in Obesity: A Novel Population-level System Dynamics Approach
Poster, ObesityWeek 2024, San Antonio, Texas, United States
This study estimates the population-level burden of adult obesity in the US. We quantified the value of early vs. late intervention in obesity from a total system perspective, exploring effects on a variety of outcomes.
Assessing the value of managing diabetic kidney disease from a US healthcare perspective
Poster, American Diabetes Association; 84th Scientific Sessions, Orlando, Florida, United States
This study estimates the economic value of attenuating the rate of decline of eGFR to limit DKD progression.
Excess body weight contributes to a premature health economic aging of 8.3 years, equivalent to an additional annual health expenditure of $306B: Results of a US population study
Poster, American Diabetes Association; 84th Scientific Sessions, Orlando, Florida, United States
This study evaluates the population-level effects of excess body weight on US healthcare expenditure via quantification of health economic aging across the population.
The value of guideline-recommended management of type 2 diabetes: a novel population-level system dynamics approach
Poster, American Diabetes Association; 84th Scientific Sessions, Orlando, Florida, United States
This study estimated the system-level impact of adopting a holistic approach to T2D management in-line with contemporary international guidelines.
Modelling COVID-19 vaccination in the UK - Impact of the Autumn 2022 and Spring 2023 booster campaigns
Poster, 34th European Congress for Clinical Microbiology and Infectious Diseases, Barcelona, Spain
This work aligns with our paper on assessing the impact of Covid boosters, which can be found here.